Literature DB >> 11493714

Arousal effect of orexin A depends on activation of the histaminergic system.

Z L Huang1, W M Qu, W D Li, T Mochizuki, N Eguchi, T Watanabe, Y Urade, O Hayaishi.   

Abstract

Orexin neurons are exclusively localized in the lateral hypothalamic area and project their fibers to the entire central nervous system, including the histaminergic tuberomammillary nucleus (TMN). Dysfunction of the orexin system results in the sleep disorder narcolepsy, but the role of orexin in physiological sleep-wake regulation and the mechanisms involved remain to be elucidated. Here we provide several lines of evidence that orexin A induces wakefulness by means of the TMN and histamine H(1) receptor (H1R). Perfusion of orexin A (5 and 25 pmol/min) for 1 hr into the TMN of rats through a microdialysis probe promptly increased wakefulness for 2 hr after starting the perfusion by 2.5- and 4-fold, respectively, concomitant with a reduction in rapid eye movement (REM) and non-REM sleep. Microdialysis studies showed that application of orexin A to the TMN increased histamine release from both the medial preoptic area and the frontal cortex by approximately 2-fold over the baseline for 80 to 160 min in a dose-dependent manner. Furthermore, infusion of orexin A (1.5 pmol/min) for 6 hr into the lateral ventricle of mice produced a significant increase in wakefulness during the 8 hr after starting infusion to the same level as the wakefulness observed during the active period in wild-type mice, but not at all in H1R gene knockout mice. These findings strongly indicate that the arousal effect of orexin A depends on the activation of histaminergic neurotransmission mediated by H1R.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493714      PMCID: PMC55561          DOI: 10.1073/pnas.181330998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Strong rebound of wakefulness follows prostaglandin D2- or adenosine A2a receptor agonist-induced sleep.

Authors:  D Gerashchenko; Y Okano; Y Urade; S Inoué; O Hayaishi
Journal:  J Sleep Res       Date:  2000-03       Impact factor: 3.981

2.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

3.  Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat.

Authors:  J S Lin; Y Hou; K Sakai; M Jouvet
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

4.  Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction.

Authors:  K M Gautvik; L de Lecea; V T Gautvik; P E Danielson; P Tranque; A Dopazo; F E Bloom; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

Authors:  T E Scammell; I V Estabrooke; M T McCarthy; R M Chemelli; M Yanagisawa; M S Miller; C B Saper
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

6.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

7.  Activation of sensory nerves participates in stress-induced histamine release from mast cells in rats.

Authors:  Z L Huang; T Mochizuki; H Watanabe; K Maeyama
Journal:  Neurosci Lett       Date:  1999-08-06       Impact factor: 3.046

Review 8.  To eat or to sleep? Orexin in the regulation of feeding and wakefulness.

Authors:  J T Willie; R M Chemelli; C M Sinton; M Yanagisawa
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

9.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

10.  Sleep variables are unaltered by zolantidine in rats: are histamine H2-receptors not involved in sleep regulation?

Authors:  J M Monti; C Orellana; M Boussard; H Jantos; S Olivera
Journal:  Brain Res Bull       Date:  1990-08       Impact factor: 4.077

View more
  138 in total

1.  Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep.

Authors:  Jiming Kong; P Nicolas Shepel; Clark P Holden; Mirek Mackiewicz; Allan I Pack; Jonathan D Geiger
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

2.  Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons.

Authors:  Laurence Bayer; Mauro Serafin; Emmanuel Eggermann; Benoît Saint-Mleux; Danièle Machard; Barbara E Jones; Michel Mühlethaler
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

Review 3.  Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness.

Authors:  Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

4.  [The neurotransmitter, hypocretin. An overview].

Authors:  C Baumann; C Bassetti
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 5.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

6.  CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Authors:  Takashi Kanbayashi; Tohru Kodama; Hideaki Kondo; Shinsuke Satoh; Yuichi Inoue; Shigeru Chiba; Tetsuo Shimizu; Seiji Nishino
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

7.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

8.  Histamine innervation and activation of septohippocampal GABAergic neurones: involvement of local ACh release.

Authors:  Changqing Xu; Kimmo A Michelsen; Min Wu; Elena Morozova; Pertti Panula; Meenakshi Alreja
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

Review 9.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

10.  Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.

Authors:  Jae-Eun Kang; Miranda M Lim; Randall J Bateman; James J Lee; Liam P Smyth; John R Cirrito; Nobuhiro Fujiki; Seiji Nishino; David M Holtzman
Journal:  Science       Date:  2009-09-24       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.